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http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2014, KaohsiuAbstract Rocuronium is a nondepolarizing neuromuscular blocking agent used in anes-
thesia induction and is associated with considerable discomfort and burning pain during in-
jection, which is reported to occur in 50e80% of patients. This study was carried out
to investigate the effectiveness of intravenous paracetamol pretreatment compared with
lidocaine and normal saline to prevent rocuronium injection pain. The study included 150
ASA IeII patients undergoing elective orthopedic, gastrointestinal, and gynecological proce-
dures under general anesthesia. They were allocated into three groups according to pre-
treatment drugs: lidocaine (40 mg) (n Z 50), paracetamol (n Z 50), and normal saline
group (n Z 50). Before anesthesia induction with propofol, all patients were pretreated
with rocuronium. The pain caused by the injection was evaluated. Local signs were assessed
on the arm at the end of the injection, as well as 24 hours after recovery from anesthesia.
There were no patients with blurred speech or vision and there was no respiratory depres-
sion in any group after pretreatment with the study drug. The level of pain on injection was
statistically lower in those who had received paracetamol compared to normal saline
(p Z 0.009). There were more patients in the saline group with severe pain (p < 0.001).
Paracetamol relieved the rocuronium injection pain better than normal saline but lidocaine
was the best of the three drugs (p < 0.001).
Copyright ª 2014, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
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Table 1 Assessment of pain [14].
Pain
score
Degree of pain Response
0 None Negative response to questioning
1 Mild Pain reported in response to
questioning only without any
behavioral signs
2 Moderate Pain reported in response to
questioning and accompanied by a
behavioral sign or pain reported
spontaneously without questioning
3 Severe Strong vocal response or response
accompanied by facial grimacing, arm
withdrawal, or tears
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Rocuronium is a nondepolarizing neuromuscular blocking
agent of rapid onset and intermediate duration of action
[1,2]. It is widely used in anesthesia induction and is asso-
ciated with considerable burning pain during injection,
which has been reported to occur in 50e80% of patients
[3e8]. The factors affecting the degree of pain are the site
of injection, the dose of rocuronium, and pretreatment
with midazolam, fentanyl, remifentanil, and lidocaine
[9e12].
One hypothesis about the mechanism of pain induced by
the intravenous injection of drugs is the stimulation of
polymodal nociceptors, leading to the release of endoge-
nous pain mediators such as prostaglandins. This stimula-
tion is thought to be caused by the unphysiological
osmolarity or pH of the drug solution [13]. Although the
rocuronium preparation is isotonic, it has a pH of 4, which
may explain its association with pain on intravenous in-
jection [13].
Animal studies have revealed that the antinociceptive
effects of paracetamol reflect a combination of peripheral
and central actions resulting from COX-2 inhibition [14,15].
The peripheral action of acetaminophen suggests that
intravenous acetaminophen with venous occlusion could
decrease rocuronium injection pain. In a recent study, it
was demonstrated that paracetamol selectively suppressed
peripheral PGE2 release and increased COX-2 gene
expression in a clinical model of acute inflammation [16]. In
another study, paracetamol showed selectivity for inhibi-
tion of the synthesis of prostaglandins and related factors
[17]. Although acetaminophen does not inhibit COX en-
zymes at therapeutic concentrations in vitro, it is shown to
inhibit a variant of the COX enzymes in vivo [18]. In light of
these findings, we aimed to investigate the effect of
paracetamol on rocuronium injection pain and compare it
with lidocaine and normal saline, as there was no study
investigating this in the literature.
Materials and methods
After institutional ethics committee approval, written
informed consent was obtained from 150 ASA IeII patients
undergoing elective orthopedic, gastrointestinal, and gy-
necological procedures under general anesthesia. The
study lasted for 3 months and was carried out in a university
hospital.
Patients with chronic pain syndromes, neurological
deficits, thrombophlebitis, difficult venous access and
estimated difficult airway, patients with paracetamol and
local anesthetic allergies, and those who had taken an
analgesic within the previous 24 h were excluded. Subjects
were randomly allocated to one of three groups by a
computer-generated randomized number in a sealed en-
velope. The test solutions were prepared in identical sy-
ringes by another investigator and covered, therefore the
investigator who assessed the patient’s response was un-
aware of the group.
Patients were monitored with an electrocardiogram,
pulse oximetry, and noninvasive blood pressure measure-
ment. A 20-gauge cannula was inserted into the dorsum ofthe hand and lactated Ringer’s infusion was infused.
Lactated Ringer’s infusion was stopped and the arm with
the intravenous line was elevated for 20 seconds for gravity
to drain the venous blood. Noninvasive blood pressure
measurement using a pneumatic tourniquet inflated to
70 mmHg was used to occlude the venous drainage of the
upper arm while elevated. After lowering the arm, patients
were pretreated with one of the pretreatment solutions;
40 mg lidocaine diluted to 5 mL (Group I), 50 mg intrave-
nous paracetamol (5 mL, 10 mg/mL) (Group II) or 5 mL
normal saline (Group III). After 2 minutes stasis, the tour-
niquet was released and 0.6 mg/kg of 1% rocuronium at
room temperature was injected over 10 seconds. An inde-
pendent blinded anesthetist asked whether the patient had
any pain on the dorsum of the hand and evaluated the pain
score as 0e3 (0: no pain, 1: mild pain, 2: moderate, and 3:
severe pain, in accordance with the scale advocated by
McCrirrick and Hunter [19], Table 1) during the injection of
the pretreatment drug and rocuronium. Immediately after
the evaluation of the pain, general anesthesia was induced
with propofol and fentanyl. The anesthesia was continued
with an appropriate technique at the discretion of the
attending anesthetist.
Signs of neuromuscular blockage effects, such as
impaired speech, blurred vision, or respiratory depression
were recorded. Local signs such as erythema and redness
on the arm where rocuronium was injected were assessed
at the end of the injection as well as 24 hours after re-
covery from anesthesia [20].
Statistical analysis
All statistical analyses were performed using the Statistical
Package for Social Sciences (SPSS 9.05 for Windows; SPSS
Inc. Chicago, IL, USA). Based on the estimated incidence of
80%, a power analysis indicated that a sample size of 50
patients per group was sufficient to have 80% power (type II
error bZ 0.2) to detect 50% difference in the incidence of
pain among three groups at 95% significance level (type I
error a Z 0.05). Patient characteristics were analyzed
using one-way ANOVA and Chi-square tests. The Kruskal-
Wallis test was used for the incidence of rocuronium in-
jection pain. Statistical significance was defined as
p < 0.05.







Age, y 41.8  13.9 42.7  11.9 41.7  13.3
Body weight, kg 73.3  14.5 68.7  14.9 71  12.2
Sex, M/F 20/30 21/29 21/29
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There were no differences between the three groups in
respect to age, body weight, and sex distribution (Table 2).
There were no patients with impaired speech or blurred
vision or respiratory depression in any group after the
pretreatment drug injection.
The overall incidence of rocuronium injection pain in the
three groups is shown in Table 3. The incidence of severe
pain related to pretreatment drug injection was 2% in the
lidocaine group, whereas there were no patients with se-
vere pain in the intravenous paracetamol and normal saline
groups. Thirty-eight patients (76%) in the lidocaine group,
45 patients (90%) in the intravenous paracetamol group and
46 patients (92%) in the normal saline group had no pain on
pretreatment drug injection. There was a statistically sig-
nificant difference between the lidocaine and normal saline
groups (p Z 0.024).
During the first 24 hours after the operation, there were
no complications such as redness, tenderness, pain, or
allergic reaction at the injection site.
Discussion
In this study, it was demonstrated that intravenous para-
cetamol was effective in preventing rocuronium injection
pain during anesthesia induction compared with normal
saline but was not better than lidocaine. The injection pain
can be attenuated by pretreatment with intravenous lido-
caine [7,8,21]. Cheong and Wong compared the influence of
two doses of lidocaine pretreatment (10 mg and 30 mg, 10
seconds after pretreatment) in adult patients and found
that both significantly reduced the incidence and severity
of the pain, and that larger doses were more effective [8].
Previous studies have shown that the incidence of rocuro-
nium injection pain was 7% with 30 mg lidocaine, 37% with
10 mg lidocaine and 77% with saline pretreatment [8].
Ahmad et al. found an incidence of 30% with 40 mgTable 3 Pain assessment of patients after pretreatment and ro
Degree of pain After pretreatment
Lidocaine Paracetamol Normal s
0 (none) 38 (76%) 45 (90%) 46 (92
1 (mild) 8 (16%)b 5 (10%) 4 (8%
2 (moderate) 3 (6%)b 0 (0%) 0 (0%
3 (severe) 1 (2%)b 0 (0%) 0 (0%
a p Z 0.009, lidocaine group vs. paracetamol group.
b p Z 0.024, lidocaine group vs. normal saline group.
c p < 0.001, paracetamol group vs. normal saline group.lidocaine and 57% with saline pretreatment without tour-
niquet technique and with an interval of 2 minutes between
lidocaine and rocuronium injection [10]. We have selected
the same dose as in the previous study with venous occlu-
sion and gravity drainage technique. Another reason for the
lidocaine dose was to enable the double blindness of the
study, as 5 mL lidocaine is equivalent to 40 mg (0.8%). In our
study, 40 mg intravenous lidocaine produced a statistically
significant reduction in the incidence of pain compared
with saline (pZ 0.009). The proportion of patients with no
pain was 48%. This is the first study showing the effect of
intravenous paracetamol in the prevention of rocuronium
injection pain using the venous occlusion method.
The incidence of pain during the injection related to
pretreatment drugs has to be considered when choosing the
pretreatment drug. Mild pain during intravenous pretreat-
ment with paracetamol was 10%, as compared with 24% for
lidocaine and 8% for saline groups in this study. Paracetamol
caused less pain during pretreatment compared with lido-
caine (p Z 0.009). This is an advantage over lidocaine.
Trying to treat the painful state with a painful drug is not
rational. The perfect technique does not yet exist but the
best method seems to be lidocaine pretreatment as it
demonstrates more potent pain relief.
The mechanism of rocuronium injection pain is still un-
clear. Peripheral veins are innervated with nociceptors that
mediate the response to the injection of certain anes-
thetics that cause pain [13]. Recently, it was concluded
that the algogenic effect of aminosteroidal neuromuscular-
blocking drugs could be attributed to a direct activation of
C-nociceptors. Rocuronium injection increases bradykinin
concentrations in the skin, and the algogenic effect of
rocuronium may result from direct activation of C-noci-
ceptors with concomitant release of the calcitonin gene-
related peptide and prostaglandin E2 [21]. Another mech-
anism of pain after rocuronium injection may be the
release of local mediators such as histamine and kinins.
Lack of erythema and warmth in the surrounding tissue
after injection, however, makes histamine release unlikely
[22].
Venous occlusion allows the study of the peripheral ac-
tion of drugs without a central effect, similar to a Bier block
[23]. It is a technique that has been used for the pre-
treatment of rocuronium injection pain [7,24]. It is suitable
for studying the peripheral action of pretreatment drugs as
in our study. The use of lidocaine for the prevention of pain
caused by the injection of some anesthetic drugs is well
established in the literature [8].curonium.
After rocuronium
aline Lidocaine Paracetamol Normal saline
%) 24 (48%)a 11 (22%)c 1 (2%)
) 17 (34%) 22 (44%)c 10 (20%)
) 6 (12%)a 14 (28%) 16 (32%)
) 3 (6%) 3 (6%)c 23 (46%)
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cated by McCrirrick and Hunter graded between 0 and 3
[19]. This verbal rating scale has been used in several re-
ports to assess the intensity of rocuronium injection pain
[22,24]. We questioned the patients when they were
awake. Because the patients were not asleep, the evalua-
tion result is more accurate.
Limitation
There was no rescue medicine to alleviate the injection
pain of the patients in saline group. This was a weakness of
the study.
Conclusion
In conclusion, we demonstrated that intravenous paracet-
amol (50 mg) is effective in decreasing the intensity of
rocuronium injection pain compared to lidocaine but is not
as effective as lidocaine and it does not cause any injection
pain by itself. This result leads us to believe that the
mechanism of rocuronium pain is very closely related to the
release of local mediators and that acute inflammation is
revealed by intravenous paracetamol.
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